References
- Guldholt I, Espersen T. Maternal febrile morbidity after cesarean section. Acta Obstet Gynecol Scand 1987; 66: 675–9
- Hägglund L, Christensen K K, Christensen P, Kamme C. Risk factors in cesarean section infection. Obstet Gynecol 1983; 62: 145–50
- Nielsen T F, Hökegård K H. Postoperative cesarean section morbidity: A prospective study. Am J Obstet Gynecol 1983; 146: 911–6
- Duff P. Prophylactic antibiotics for cesarean delivery: A simple cost-effective strategy for prevention of postoperative morbidity. Am J Obstet Gynecol 1987; 157: 794–8
- Gonik B. Single- versus three-dose cefotaxime prophylaxis for cesarean section. Obstet Gynecol 1985; 65: 189–93
- McGregor J A, French C MJI, Makowski E. Single-dose cefotetan versus multidose cefoxitin for prophylaxis in cesarean section in high-risk patients. Am J Obstet Gynecol 1986; 154: 955–60
- Jakobi P, Weissman A, Zimmer E Z, Paldi E. Single-dose cefazolin prophylaxis for cesarean section. Am J Obstet Gynecol 1988; 158: 1049–52
- Brogden R N, Heel R C, Speight T M, Avery G S. Cefuroxime: A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs 1979; 17: 233–66
- Pritchard J M, Elder M G, Kennedy M RK. Pelvic tissue levels of cefuroxime. J Infect 1981; 3: 192–7
- Sôrensen T S, Aabech J, Utzon N P, Bruun B, Lorentzen J E. Kinetics of cefuroxime in the groin wound after vascular prosthetic implantation. J Vase Surg 1988; 8: 143–6
- Persson E, Brihmer C, Forslin L, et al. Uterine and wound infections following cesarean section. Acta Obstet Gynecol Scand 1983; 62(Suppl. 116)107–9
- Stiver H G, Forward K R, Tyrrell D L, et al. Comparative cervical microflora shifts after cefoxitin or cefazolin prophylaxis against infection following cesarean cestion. Am J Obstet Gynecol 1984; 149: 718–21
- Gibbs R S, Clair P JS, Castillo M S, Castaneda Y S. Bac-teriologic effects of antibiotic prophylaxis in high risk cesarean section. Obstet Gynecol 1981; 57: 277–82